BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
©The Author(s) 2021.
World J Clin Cases. Jul 16, 2021; 9(20): 5479-5489
Published online Jul 16, 2021. doi: 10.12998/wjcc.v9.i20.5479
Table 1 Baseline characteristics of patients, procedure time and total propofol dosages
CharacteristicWNJT group, n = 49Nasal cannula group, n = 52P value
Age (yr)37.89 ± 13.737.5 ± 12.50.892
Height (m)1.7 ± 0.11.7 ± 0.10.293
Weight (kg)100.7 ± 17.096.4 ± 18.20.217
Sex (M/F)19/3016/360.398
Body mass index (kg/m2)35.6 ± 4.834.7 ± 4.10.316
Baseline SpO2 (%)97.1 ± 1.597.1 ± 1.60.982
ASA physical status grade (I/II)22/2723/290.946
Procedure times (min)4.6 ± 0.94.8 ± 0.40.065
Total propofol dosages (mg)229.4 ± 41.7210.2 ± 45.40.030
Table 2 The lowest pulse oxygen saturation, interventions related to hypoxemia and adverse events
WNJT group, n = 49Nasal cannula group, n = 52P value
Lowest SpO2 during gastroscopy95.5 ± 4.390.0 ± 7.00.000
Airway opening maneuvers7 (14.3)36 (69.2)0.000
Facemask ventilation0 (0)4 (7.7)0.118
Body movement7 (14.3)5 (9.6)0.468
Cough5 (10.2)4 (7.7)0.926
Epistaxis (0/1/2/3)0/2/1/0 (6.1)0/0/0/0 (0)0.111
Sore throat2 (4.1)1 (1.9)0.610
Table 3 Satisfaction of physicians, anesthetists and patients

WNJT group, n = 49
Nasal cannula group, n = 52
P values
Good
Fair
Poor
Good
Fair
Poor
Physicians49 (100)0 (0)0 (0)46 (88.5)5 (9.6)1 (1.9)0.015
Anesthetists46 (93.9)2 (4.1)1(2.0)38 (73.1)12 (23.1)2 (3.8)0.006
Patients49 (100)0 (0)0(0)52 (100)0 (0)0 (0)1.000


Write to the Help Desk